1. Home
  2. KBSX vs GANX Comparison

KBSX vs GANX Comparison

Compare KBSX & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KBSX
  • GANX
  • Stock Information
  • Founded
  • KBSX 1976
  • GANX 2017
  • Country
  • KBSX Taiwan
  • GANX United States
  • Employees
  • KBSX N/A
  • GANX N/A
  • Industry
  • KBSX Recreational Games/Products/Toys
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • KBSX Consumer Discretionary
  • GANX Health Care
  • Exchange
  • KBSX Nasdaq
  • GANX Nasdaq
  • Market Cap
  • KBSX 67.6M
  • GANX 79.8M
  • IPO Year
  • KBSX N/A
  • GANX 2021
  • Fundamental
  • Price
  • KBSX $1.69
  • GANX $1.95
  • Analyst Decision
  • KBSX
  • GANX Strong Buy
  • Analyst Count
  • KBSX 0
  • GANX 6
  • Target Price
  • KBSX N/A
  • GANX $8.00
  • AVG Volume (30 Days)
  • KBSX 25.0K
  • GANX 841.3K
  • Earning Date
  • KBSX 08-21-2025
  • GANX 11-13-2025
  • Dividend Yield
  • KBSX N/A
  • GANX N/A
  • EPS Growth
  • KBSX N/A
  • GANX N/A
  • EPS
  • KBSX N/A
  • GANX N/A
  • Revenue
  • KBSX $40,863,331.00
  • GANX N/A
  • Revenue This Year
  • KBSX N/A
  • GANX N/A
  • Revenue Next Year
  • KBSX N/A
  • GANX N/A
  • P/E Ratio
  • KBSX N/A
  • GANX N/A
  • Revenue Growth
  • KBSX 20.42
  • GANX N/A
  • 52 Week Low
  • KBSX $1.26
  • GANX $1.41
  • 52 Week High
  • KBSX $15.48
  • GANX $3.19
  • Technical
  • Relative Strength Index (RSI)
  • KBSX 62.96
  • GANX 55.24
  • Support Level
  • KBSX $1.45
  • GANX $1.93
  • Resistance Level
  • KBSX $1.53
  • GANX $2.40
  • Average True Range (ATR)
  • KBSX 0.07
  • GANX 0.18
  • MACD
  • KBSX 0.02
  • GANX 0.03
  • Stochastic Oscillator
  • KBSX 83.33
  • GANX 38.89

About KBSX FST Corp. Ordinary Shares

FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: